Cencora Inc

CEO Robert Mauch sells 1,333 shares of Cencora stock a day after the $3.5 B Covetrus merger, indicating routine liquidity management amid a promising veterinary tech expansion.

Insider buying by Cencora’s executive Silvana signals confidence in the firm’s rebound, amid high P/E, positive sentiment and a near‑peak stock price.